BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao CY, Jiang LL, Li L, Deng ZJ, Liang BL, Li JM. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver disease. World J Gastroenterol 2004; 10(9): 1329-1332 [PMID: 15112352 DOI: 10.3748/wjg.v10.i9.1329]
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1329.htm
Number Citing Articles
1
S. Dharancy, A. Louvet, A. Hollebecque, P. Desreumaux, P. Mathurin, L. Dubuquoy. Récepteurs nucléaires PPAR et hépatologie : implications physiopathologiques et thérapeutiquesGastroentérologie Clinique et Biologique 2008; 32(3): 339 doi: 10.1016/j.gcb.2008.01.029
2
Araní Casillas-Ramírez, Izabel Alfany-Fernández, Marta Massip-Salcedo, M. Emília Juan, Joana M. Planas, Anna Serafín, Mercè Pallàs, Antoni Rimola, Juan Rodés, Carmen Peralta. Retinol-Binding Protein 4 and Peroxisome Proliferator-Activated Receptor-γ in Steatotic Liver TransplantationJournal of Pharmacology and Experimental Therapeutics 2011; 338(1): 143 doi: 10.1124/jpet.110.177691
3
Wen Deng, Zimin Meng, Aitao Sun, Zhihong Yang. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro studyCancer Biomarkers 2017; 20(4): 411 doi: 10.3233/CBM-170157
4
Jhao-Ru Lai, Ya-Wen Hsu, Tzu-Ming Pan, Chun-Lin Lee. Monascin and Ankaflavin of Monascus purpureus Prevent Alcoholic Liver Disease through Regulating AMPK-Mediated Lipid Metabolism and Enhancing Both Anti-Inflammatory and Anti-Oxidative SystemsMolecules 2021; 26(20): 6301 doi: 10.3390/molecules26206301
5
Nora A. Ashry, Rania R. Abdelaziz, Ghada M. Suddek. The potential effect of imatinib against hypercholesterolemia induced atherosclerosis, endothelial dysfunction and hepatic injury in rabbitsLife Sciences 2020; 243: 117275 doi: 10.1016/j.lfs.2020.117275
6
Kenichi Harada, Kumiko Isse, Takashi Kamihira, Shinji Shimoda, Yasuni Nakanuma. Th1 cytokine–induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosis†Hepatology 2005; 41(6): 1329 doi: 10.1002/hep.20705
7
Bessem Mornagui, Raja Rezg, Fadoua Neffati, Mohamed Fadhel Najjar, Ahmed Rejeb. Postnatal exposure to Bisphenol S induces liver injury in mice: Possible implication of PPARγ receptorToxicology and Industrial Health 2023; 39(5): 237 doi: 10.1177/07482337231166490
8
Jhao-Ru Lai, Bo-Jun Ke, Ya-Wen Hsu, Chun-Lin Lee. Dimerumic acid and deferricoprogen produced by Monascus purpureus attenuate liquid ethanol diet-induced alcoholic hepatitis via suppressing NF-κB inflammation signalling pathways and stimulation of AMPK-mediated lipid metabolismJournal of Functional Foods 2019; 60: 103393 doi: 10.1016/j.jff.2019.05.049
9
Sapana Bansod, Mohd Aslam Saifi, Chandraiah Godugu. Molecular updates on berberine in liver diseases: Bench to bedsidePhytotherapy Research 2021; 35(10): 5459 doi: 10.1002/ptr.7181
10
Elena Grasselli, Adriana Voci, Ilaria Demori, Rita De Matteis, Andrea D. Compalati, Gabriella Gallo, Laura Vergani. Effects of binge ethanol on lipid homeostasis and oxidative stress in a rat model of nonalcoholic fatty liver diseaseJournal of Physiology and Biochemistry 2014;  doi: 10.1007/s13105-013-0308-x
11
Warinda Susutlertpanya, Duangporn Werawatganon, Prasong Siriviriyakul, Naruemon Klaikeaw. Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγin a Rat ModelEvidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/509057
12
Naruemon Klaikeaw, Jutamas Wongphoom, Duangporn Werawatganon, Maneerat Chayanupatkul, Prasong Siriviriyakul. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitisWorld Journal of Hepatology 2020; 12(7): 364 doi: 10.4254/wjh.v12.i7.364
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
13
Naruemon Klaikeaw, Jutamas Wongphoom, Duangporn Werawatganon, Maneerat Chayanupatkul, Prasong Siriviriyakul. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitisWorld Journal of Hepatology 2020; 12(7): 363-377 doi: 10.4254/wjh.v12.i7.363
14
Xin Xin, Cheng Chen, Yi-Yang Hu, Qin Feng. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)Biomedicine & Pharmacotherapy 2019; 117: 109047 doi: 10.1016/j.biopha.2019.109047
15
Suchittra Samuhasaneeto, Duangporn Thong-Ngam, Onanong Kulaputana, Doungsamon Suyasunanont, Naruemon Klaikeaw, Stelvio M. Bandiera. Curcumin Decreased Oxidative Stress, Inhibited NF‐κB Activation, and Improved Liver Pathology in Ethanol‐Induced Liver Injury in RatsBioMed Research International 2009; 2009(1) doi: 10.1155/2009/981963
16
Chuan Shen, Cai-Yan Zhao, Wei Wang, Ya-Dong Wang, Hui Sun, Wei Cao, Wei-Yan Yu, Li Zhang, Ru Ji, Meng Li, Jian Gao. The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitisBMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-39
17
WEIHAN ZHAO, LIJUAN LIU, YUNLIANG WANG, TANGYOU MAO, JUNXIANG LI. Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver diseaseExperimental and Therapeutic Medicine 2016; 11(1): 183 doi: 10.3892/etm.2015.2846
18
Nora A. Ashry, Rania R. Abdеlaziz, Ghada M. Suddek, Mohamed A. Saleh. Canagliflozin ameliorates aortic and hepatic dysfunction in dietary-induced hypercholesterolemia in the rabbitLife Sciences 2021; 280: 119731 doi: 10.1016/j.lfs.2021.119731
19
H ELKATTAWY, D MAHMOUD ABDELMONEM ELSHERBINI, H ALI EBRAHIM, D ABDULLAH, S AL-ZAHABY, Y NOSERY, A EL-SAYED HASSAN. Rho-Kinase Inhibition Ameliorates Non-Alcoholic Fatty Liver Disease in Type 2 Diabetic RatsPhysiological Research 2022; : 615 doi: 10.33549/physiolres.934869
20
M. Elias-Miró, M. B. Jiménez-Castro, M. Mendes-Braz, A. Casillas-Ramírez, C. Peralta. The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion InjuryPPAR Research 2012; 2012: 1 doi: 10.1155/2012/802384